Announcements
- Update on settlement
- Holding(s) in Company - Replacement
- Holding(s) in Company
- New shares registered with Finnish Trade Register
- Fully subscribed EUR 30.7 million share offering
- Proposed REX Retail Offer
- Faron commences a share offering
- Initial positive data from Phase 2 of BEXMAB
- Issuance of warrants
- Founders named European Inventor Award finalists
More ▼
Key statistics
On Friday, Faron Pharmaceuticals Oy (4FR:FRA) closed at 1.10, 5.59% above its 52-week low of 1.04, set on Jun 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.10 |
---|---|
High | 1.10 |
Low | 1.10 |
Bid | 1.12 |
Offer | 1.16 |
Previous close | 1.12 |
Average volume | 0.00 |
---|---|
Shares outstanding | 104.62m |
Free float | 71.27m |
P/E (TTM) | -- |
Market cap | 98.19m GBP |
EPS (TTM) | -0.2815 GBP |
Data delayed at least 15 minutes, as of Jul 05 2024 07:29 BST.
More ▼